Physician

Aaron Fabian Brafman, M.D.

According to 2025 Medicare claims, Aaron Brafman, M.D. (NPI: 1730441841) practices urology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is GENESISCARE USA OF FLORIDA LLC (NPI: 1013386952; TIN: 592485899) and primary practice location at 33071-6053.

Brafman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 472 traditional Medicare patients, billed 6,131 HCPCS/CPT codes, and received $263,407 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,007 prescription claims across 707 beneficiaries totaling $2,305,038 in drug costs, led by Xtandi (Enzalutamide). DME data shows 38 claims. Open Payments data shows 79 records totaling $1,890. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $21,069 to $263,407. Similarly, Part D prescription costs have moved sharply higher in recent years, from $758 to $2,305,038. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $360 to $834.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	70	322	$21,069
2018	390	2,549	$146,409
2019	466	3,518	$188,641
2020	407	4,150	$179,579
2021	447	5,816	$229,466
2022	423	7,208	$247,694
2023	454	6,071	$189,343
2024	472	6,131	$263,407

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	47	78	$758
2016	112	183	$1,876
2017	55	88	$2,319
2018	351	1,133	$91,866
2019	495	2,067	$220,733
2020	473	2,151	$520,840
2021	536	2,255	$521,818
2022	605	2,415	$638,354
2023	621	2,751	$1,181,589
2024	707	3,007	$2,305,038

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	51	$25,967
2021	N/R	50	$25,374
2022	N/R	45	$23,206
2023	N/R	46	$24,933
2024	N/R	38	$27,071

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	343	613	$99
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	194	277	$73
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	367	691	$13
51798	Ultrasound measurement of bladder capacity after voiding	397	778	$9
81002	Urinalysis, manual test	391	829	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	63	1,890	$890,967
Erleada	Apalutamide	38	1,140	$422,251
Orgovyx	Relugolix	82	2,456	$213,733
Lupron Depot	Leuprolide Acetate	23	2,110	$142,846
Gemtesa	Vibegron	124	7,529	$119,409

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4353	Intermittent urinary catheter, with insertion supplies	N	N/R	12	$17,950
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	26	$9,121

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	79	$1,890	PROCEPT BioRobotics Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aaron Fabian Brafman, M.D.?

Tedicare shows public-source Medicare data for Aaron Fabian Brafman, M.D. (NPI 1730441841), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Fabian Brafman, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aaron Fabian Brafman, M.D.?

Aaron Fabian Brafman, M.D. is linked to GENESISCARE USA OF FLORIDA LLC (billing NPI 1013386952) in the available physician profile data.

Does Aaron Fabian Brafman, M.D. have Open Payments data?

Aaron Fabian Brafman, M.D. has 79 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.